Lin Shao-Lee
SEC CIK 1725092 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CUE | Cue Biopharma, Inc. | CEO, Dir | 706.0K | — | $1.61M | 4 | 2026-05-03 | 2026-08-12 |
Most active insiders at CUE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lin Shao-Lee | CEO, Dir | — | $1.61M |
| 2 | Ray Sumita | Chief Legal Compliance Off, Corp. Sec | — | $265.6K |
| 3 | Meluzio Michael Vincent | VP, Prin. Accounting Off | — | $169.3K |
| 4 | Sarraf Pasha | Dir | $99.7K | — |
| 5 | Meehan Viola Mong | Dir | — | — |
| 6 | Borie Dominique Christian | Chief Medical Off, Head of Research, Development | — | — |
| 7 | Garzone Pamela | Dir | — | — |
| 8 | Camardo Daniel A. | Dir | — | — |
| 9 | Ahlers James M | CFO | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-14 20:46 | 2026-08-12 | CUE | Cue Biopharma, Inc. | Lin Shao-Lee | CEO, Dir | M - OptEx | $0.00 | +109.2K | 764.3K | +17% | $0 |
| DM | 2026-08-14 20:46 | 2026-08-12+ | CUE | Cue Biopharma, Inc. | Lin Shao-Lee | CEO, Dir | S - Sale+OE | $27.58 | -58.3K | 706.0K | -8% | -$1.61M |
| D | 2026-07-10 19:32 | 2026-07-09 | CUE | Cue Biopharma, Inc. | Lin Shao-Lee | CEO, Dir | A - Grant | $0.00 | +327.5K | 655.1K | +100% | $0 |
| D | 2026-05-07 16:00 | 2026-05-03 | CUE | Cue Biopharma, Inc. | Lin Shao-Lee | CEO, Dir | A - Grant | $0.00 | +327.5K | 327.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations